99% Purity Cartalax CAS 45234-02-4 Raw Peptide Factory Supply High Quality Low Price
TDS 10 Inquiries
45234-02-4
Pharmaceutical Grade
99%
HongKong
XY
10mg
2029-01-01
Retatrutide,Tirzepitide,peptide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceWhite powder
Solid
Lys-Glu is a dipeptide formed from L-lysine and L-glutamic acid residues. It has a role as a metabolite.Certificates-
TDS
Basic Info-
Product Name:
Lysylglutamic acid
Other Name:L-Glutamic acid,L-lysyl-;L-Glutamic acid,N-L-lysyl-;Glutamic acid,N-L-lysyl-;L-Lysyl-L-glutamic acid;Lysylglutamic acid;Vilon;Vilon (peptide);1072: PN: EP2071334 SEQID: 1140 claimed protein;1072: PN: WO2009077864 SEQID: 1140 claimed protein;72: PN: EP2161028 PAGE: 10 claimed protein;911649-46-2
CAS No.:45234-02-4
Molecular Formula:C11H21N3O5
InChIKeys:InChIKey=UGTZHPSKYRIGRJ-YUMQZZPRSA-N
Molecular Weight:275.3
Exact Mass:275.30
UNII:H34V7IM5ML
DSSTox ID:DTXSID50196442
HScode:2924199090
Categories:
Characteristics-
PSA:
156
XLogP3:0.66840
Density:1.29 g/cm3
Melting Point:195-197 °C
Boiling Point:596.4ºC at 760 mmHg
Flash Point:314.5ºC
Storage Conditions:-15°C
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Retatrutide,Tirzepitide,peptide
-
Location:
Room 3, 13th Floor, New Oriental Building, Northeast 4th Street, Dalian Free Trade Zone, Dalian City, Liaoning Province, P.R. China
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
101-200
-
Year of Establishment:
2013
-
-
Inquiry History10 Inquiries
Country Product Purchase Quantity Date Posted
United Arab Emirates
Vesugen Peptide 98% Powder 45234-02-4 Senwayer
1 G Nov 14, 2023
United States
Cartalax
20 MG Aug 6, 2026
United States
Vilon
1 KG Jul 8, 2026
Brazil
Cartalax
5 MT Apr 17, 2026
United States
Cartalax
20 MG Aug 17, 2026
Australia
Cartalax
200 MG Jul 3, 2026
United States
Cartalyx
1 PCS Mar 12, 2026
United States
Cartalax
1 G Jul 25, 2026
Netherlands
Cartalax
1 G Apr 26, 2026
United States
Vesugen 10mg
20 PCS Mar 3, 2026 Post an enquiry for this product